Estimating and Predicting Hemodynamic Changes During Hemodialysis

December 1, 2016 updated by: University of Colorado, Denver
Machine learning techniques and algorithms originally developed for use in the field of robotics can be applied to continuous, noninvasive physiological waveform data to discover hidden, hemodynamic relationships. Newly developed algorithms can, in real-time: 1) estimate acute blood loss volume, 2) monitor and estimate fluid resuscitation needs, 3) predict cardiovascular collapse well ahead of any clinically significant changes in standard vital signs, and 4) estimate intracranial pressure. We hypothesize that these same methods can be used to monitor volume loss during hemodialysis, as well as predict intradialytic hypotension, well before it occurs.

Study Overview

Status

Completed

Conditions

Detailed Description

  1. Collect physiological waveform data from patients undergoing hemodialysis at the University of Colorado Hospital, Children's Hospital Colorado, and Fresenius Medical Centers using non-invasive monitoring techniques.
  2. Combine the physiological data from patient monitors with clinical and demographic data, including age, gender, race, problem list, reason for dialysis, estimated dry weight, volume removed, arterial and venous pressures, etc. for use in developing mathematical models of hemodialysis.
  3. Develop robust, real-time, computational models for:

    • estimating acute intravascular volume loss during hemodialysis
    • predicting an optimal, individual specific, intravascular volume to be removed during a hemodialysis session
    • predicting intradialytic hypotension
  4. Determine:

    • which non-invasive signals are relevant to each model type
    • which features extracted from these signals are relevant
    • which algorithms are capable of using the extracted features for each decision type

Study Type

Observational

Enrollment (Actual)

241

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • Children's Hospital Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Hospital
      • Aurora, Colorado, United States, 80011
        • Fresenius Medical Center East Denver
      • Denver, Colorado, United States, 80209
        • Fresenius Medical Center Central
      • Denver, Colorado, United States, 80220
        • Fresenius Medical Center Rocky Mountain

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 89 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult and pediatric patients undergoing hemodialysis at Fresenius Medical Centers, University of Colorado Hospital or Children's Hospital Colorado will be the population base for enrollment in this study. Patients may have acute kidney injury or end stage renal disease. Subjects may be inpatients or outpatients.

Description

Inclusion Criteria:

  • Age: 2 - 89 years
  • Undergoing hemodialysis at the Fresenius Medical Centers, University of Colorado Hospital or Children's Hospital Colorado

Exclusion Criteria:

  • Pregnant
  • Incarcerated
  • Decisionally challenged
  • Positive for hepatitis B surface antigen
  • Limited access to or compromised monitoring sites for non-invasive finger and ear or forehead sensors

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Hemodialysis
Patients undergoing hemodialysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acute intravascular volume loss during hemodialysis
Time Frame: one hemodialysis session (approx 3-4 hours)
development of algorithm to estimate acute intravascular volume loss during hemodialysis
one hemodialysis session (approx 3-4 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (ACTUAL)

December 1, 2016

Study Completion (ACTUAL)

December 1, 2016

Study Registration Dates

First Submitted

September 27, 2012

First Submitted That Met QC Criteria

October 3, 2012

First Posted (ESTIMATE)

October 4, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

December 5, 2016

Last Update Submitted That Met QC Criteria

December 1, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 11-1437

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis

3
Subscribe